SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway
Xingchen Peng(Sichuan University), Youxue Zhao(Sichuan University)
Cited by 27
Related Papers
Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk
|Frontiers in Immunology|2023|40
Survival outcomes following treatment delays among patients with early-stage female cancers: a nationwide study
|Journal of Translational Medicine|2022|32
Prognostic nomogram for adenoid cystic carcinoma in different anatomic sites
|Head & Neck|2020|29